US Stock MarketDetailed Quotes

AEON AEON Biopharma

Watchlist

1.400
+0.340+32.08%

Close Jul 12 16:00 ET

1.450
+0.050+3.57%

Post 19:35 ET

54.77MMarket Cap-135P/E (TTM)

AEON Biopharma Stock Forum

Rasel1

May 31 09:45

$AEON Biopharma(AEON.US)$ it will go up

MessaMel

May 22 14:19

$AEON Biopharma(AEON.US)$ $InMed Pharmaceuticals(INM.US)$ $Rubicon Technologies(RBT.US)$ $Greenlane(GNLN.US)$

MoshDawg

May 16 15:15

$AEON Biopharma(AEON.US)$ coming off the watchlist. Company has never turned a profit since it started (common enough for pharmaceutical R&D company like this), quarterly report seems to confirm their flagship product development is ineffective. Company will need to do some serious cap raising to stay afloat. Leave this one and take your money elsewhere.

MoshDawg

May 14 13:26

$AEON Biopharma(AEON.US)$ on the watchlist, phase 2 trial seemed okay other than unexpectedly strong result from placebo, interested to see how phase 3 goes. Might look to enter if price goes lower.

BSDLucky

May 3 09:33

Depressing

$AEON Biopharma(AEON.US)$
this is depressing. wonder will the counter just get itself delisted from the market? people just treat the compat withour any single hope?

Johnny Mnemonic

May 3 08:11

this is a buy for me, 5 leg was basically already completed before this negative news and had been in a downtrend since mid March

Jaguar8

May 3 06:01

$AEON Biopharma(AEON.US)$
NEWS
AEON Biopharma Announces Preliminary Top-Line Results from Phase 2 Interim Analysis of ABP-450 in the Preventive Treatment of Chronic Migraine
AEON Biopharma announced that the preliminary results from the Phase 2 trial with ABP-450 for chronic migraine prevention did not meet the primary endpoint of mean reduction in monthly migraine days. The trial showed no statistical significance in reduction compared to placebo, leading to the company initiating cash preserva...

Trytosaveabit

Mar 19 15:34

$AEON Biopharma(AEON.US)$ Press Release: AEON Biopharma Announces $15 Million Financing Transaction and Termination of Forward Purchase Agreements
Dow Jones· 5 mins ago

Trytosaveabit

Mar 19 15:32

$AEON Biopharma(AEON.US)$ AEON Biopharma Announces Clinical Update and Productive End-of-Phase 2 Meeting with FDA on ABP-450 (prabotulinumtoxinA) for the Preventive Treatment of Migraine
1 MINUTE AGO, 4:30 PM EDT
VIA GLOBENEWSWIRE
– FDA and AEON align on the design and endpoints for the proposed pivotal Phase 3 trials for the preventive treatment of both episodic and chronic migraine –
– An interim analysis from the ongoing Phase 2 study in chronic migraine will now be conducted and data are e...

amusing Dinosaur_870

Sep 10, 2023 14:19

$AEON Biopharma(AEON.US)$ Daewoong Pharmaceutical’s botulinum toxin product Nabota (U.S. name: Jeuveau) was patented in the U.S. as a neurotoxin composition for treating headaches through its U.S. partner, $AEON Biopharma, with exclusive rights until 2041.
https://www.koreabiomed.com/news/articleView.html?idxno=22014

No comment yet

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

Concept

Top Gainers Yesterday

Intraday+0.91%